Adam

New gene therapy to treat rare inherited blood condition

EMA has recommended granting a marketing authorisation in the European Union for a genetically modified product for beta-thalassaemia, a rare inherited blood condition  that causes severe anaemia.  Zynteglo is intended for adult and adolescent patients 12 years and older  who need regular blood transfusions to manage their disease and have no matching donor for a […]